24 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Call for Applications: 2014 Association of Women Surgeons Foundation/Ethicon Endo-Surgery, Inc. Fellowship
A one year grant of $25,000 will be awarded to a qualified and approved grant applicant in the following research topic areas:
• Bariatrics
• Minimally Invasive Surgery
• Cancer Related Research
• Surgical Education
• Surgical Innovation
Applicant Qualifications
• Applicants must be a non-tenure or tenure-track faculty member in a Department of Surgery.
• Junior faculty applicants are encouraged to have a mentor for the submitted research proposal.
• Must be a current AWS member in good standing.
Individuals with research support such as national extramural grants are eligible, provided the projects do not have scientific overlap. Applicants who do not have funding from other surgical societies will be given priority. Officers and members of the AWS Grants and Fellowship Committee are excluded from mentoring applicants.
Grant Submissions are due July 1, 2013
For more information, contact AWSF at 5204 Fairmount Avenue - Downers Grove, IL 60515 Phone: 708-226-2725 - Fax: 630-493-0798
Email: INFO@WomenSurgeons.org or visit our Website at WomenSurgeons.org.
Call for Applications: HERA Women’s Cancer Foundation Community Grants Program
HERA provides support for local ovarian cancer groups via program development and through the HERA Community Grants program.
Grants are available for ovarian cancer support and awareness programs.
The HERA Women’s Cancer Foundation is now accepting applications for its Community Grants Program.
Applications are due June 3, 2013.
These $1,000 grants will be awarded to 501(c)(3) organizations for programs that improve the quality-of-life for women with ovarian cancer or raise awareness about the disease in novel and unusual ways.
The grant application deadline is June 1st of each year. Organizations can receive support for up to 3 years in a row.
Interested grassroots and community organizations are encouraged to apply.
The HERA Women’s Cancer Foundation gives five seed grants annually of $1,000 to help organizations start programs or support existing programs.
How to apply:
Download the printable Community Grant Application from the HERA Women’s Cancer Foundation website
Applicants must be a 501(c)(3) charitable organization
There is one grant cycle and grant applications must be received by June 3.
Please include the cover page with your application. An electronic copy in a single PDF file can be emailed to: Meg Steitz, Executive Director: meg@herafoundation.org
Call for Applications: HERA Women’s Cancer Foundation Sean Patrick Multidisciplinary Collaborative Grant
The HERA Women’s Cancer Foundation provides funds for a project focused on the cause, early detection, treatment, and/or understanding of ovarian cancer. This annual award provides $50,000 for a cross-disciplinary project that is collaborative in nature. The application must identify two (or more) scientists with different yet complementary skills and explain how these skills will be synergistic in addressing the ovarian cancer problem. Applications are now being accepted for the 2013 award.
Sean Patrick, for whom this grant was named, was a champion for innovative ovarian cancer research. She was frustrated by the disproportionate amount of government funds that went to other cancers and that the traditional chemotherapies had not changed the prognosis of ovarian cancer in decades. To change this convention, she founded the HERA Women’s Cancer Foundation whose mission is to stop the loss of women from ovarian cancer by promoting Health, Empowerment, Research, and Awareness. Sean believed that the therapies with the most potential would be formulated by combining great ideas from different labs and possibly different fields. This grant is in honor of her vision and aims to give scientists the opportunity to put their heads together and test ideas that may not be fundable by other agencies.
Eligibility:
Scientists and clinicians of non-profit research, medical service, and educational institutions located in the U.S. are eligible and encouraged to apply.
Applications and questions should be directed to Meg Steitz, HERA’s Executive Director, meg@herafoundation.org, or (970) 948-7360.
ASCO Members in Training 2013 Best of ASCO Chicago Meeting Travel Grant
August 9-10, 2013 Chicago, Illinois
Travel Grant Application Deadline: Wednesday, July 10, 2013 at 11:59 PM (EDT)
ASCO is pleased to offer financial support for ASCO Members in Training* to attend the 2013 Best of ASCO Chicago Meeting. This travel grant is a reimbursement award (up to $600) to assist with expenses associated with attending the Meeting, including
the registration fee
coach airfare
hotel accommodations
modest meals
transportation to and from the meeting site
Travel grants will be awarded on a first come, first served basis. The number of awards is limited. To apply for the travel grant
Register for the Best of ASCO Chicago Meeting
At the end of online registration, select “Apply for Travel Grant”; this will allow you to submit a letter of recommendation from your Program Director and a copy of your CV.
Applicants must be registered in order to apply for the travel grant. ASCO will notify applicants by Friday, July 19 regarding whether they were selected to receive the travel grant..
*ASCO Members in Training membership is free for oncology fellows and oncology residents. To join ASCO, submit a membership application. Contact Member Services at membermail@asco.org, 888-282-2552, or 703-299-0158 for a Pending ID number.
Advocacy Travel Awards for the International Association for the Study of Lung Cancer 15th World Conference on Lung Cancer
October 27-30, 2013 Sydney, Australia
Award Submission Deadline: June 21, 2013
In its efforts to increase links to patient advocates and advocacy organizations around the world, IASLC will offer travel awards to a limited number of patient advocates to attend and participate in the World Conference.
Applicants for the Advocacy Travel Award will be required to submit a detailed application, a summary of expected outcomes for attending, and any other supporting documentation required for review by IASLC. Organizations that have 501(c)(3) or a similar type of non-profit status, but also individuals not affiliated with an advocacy organization may apply.
Awardees will receive:
Free Conference registration
Cash Award in the amount of 1,000 AUD to help offset travel costs
Up to 4 nights accommodation at one of the Conference contracted hotels
Free IASLC Membership for 2014
Please note that if your travel costs exceed 1,000 AUD, the Conference will unfortunately not be able to provide further financial support. Any costs exceeding 1,000 AUD will be at your own expense.
Eligibility for selection in 2013 will include:
The demonstration that the organization or individual has limited financial resources -- supported through IRS form 990 submission or other documentation;
Compatibility between IASLC and the advocate or advocacy organizations’ missions, including the ability of IASLC to benefit from and contribute to the organization’s mission;
Recent and potential future partnerships or strategic endeavors;
A detailed plan and description of how information about the conference will be shared and promoted with members of the public;
Priority will be given to first-time applicants and applicants who are not already receiving funding for attendance through their own or another organization; i.e. Global Lung Cancer Coalition;
The individual applying must be a current member of IASLC for 2013 (visit www.iaslc.org/membership to join);
For organizations applying, you must nominate ONLY ONE individual to represent the organization; multiple applications from individuals from the same organization will not be considered.
Doctors Cancer Foundation Grant Program
There will be a $50,000 grant in 2013 for the best program for the management of cancer. There may be an additional $50,000 Nolan Miller grant for the best program for lung cancer. There is a strong interest in cancer stem cells, microRNAi agents, epigenetic agents, as well as many others. We are particularly interested in promoting the best of the young scientists, currently under the radar screen. We are NOT looking at studies that show that drug A is 3% better than drug B. The project should be innovative, sound and be able to lead to clnical trials. All such projects will get equal consideration. Research grant applications should be organized as follows:
Research Hypothesis
Background and rationale
Study objectives
Study design
Study population (if applicable)
Criteria for evaluation
Definition of response
Analyses
Please make it as concise as possible, with a maximum of 10 pages, excluding references and budget. The reviewers are physicians in practice and the application should be understandable by practicing physicians. Please note the award does not include payment for the salary of the investigator, overhead or travel.
Please email the application to dcf@doctorscancerfoundation.org. The deadline for grant applications is May 31, 2013.
Call for Nominations: Carcinogenesis Awards
Carcinogenesis is pleased to invite nominations for the seventh biennial Carcinogenesis Awards. The awards are presented at the biennial meetings of the European Association for Cancer Research. The next presentation will be at the EACR's Biennial Congress: EACR-23, Munich, 5 - 8 July 2014.
SENIOR AWARD
For major contributions to research in the field of carcinogenesis. The winner will be invited to lecture on his or her work at the EACR meeting and be presented with this award and a prize of $2500.
YOUNG INVESTIGATOR AWARD
A prize of $2500 is offered for a recent, significant contribution to carcinogenesis research by an investigator under the age of 40 on 1 July 2013. The winner will be invited to the EACR meeting to give a lecture and be presented with this award.
NOMINATIONS
Nominations are now invited for these awards. Please send the name(s) and address(es) of nominee(s) to the e-mail address below by 1 July 2013, together with reasons for the recommendation, details of relevant publications and a curriculum vitae. Self nominations cannot be accepted. The decision making panel comprises the editors of Carcinogenesis and members of the Editorial Board. A final decision will be made by the end of 2013.
Address for nominations by 1 July 2013 to: carcinogenesis.editorialoffice@oup.com
Cancer Research Institute Irvington Postdoctoral Fellowship Program
The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in cancer immunology.
A panel of scientists drawn from our Scientific Advisory Council rigorously evaluates each candidate, the intended sponsor and training environment, and the nature and feasibility of the proposed project.
The Institute seeks hypothesis driven, mechanistic studies in both immunology and tumor immunology. The applicant and sponsor must clearly state the potential of the proposed studies to directly impact our understanding of the immune system’s role in cancer risk, tumor initiation, progression, metastasis, host response to tumors and/or the treatment of cancer.
Eligibility
Applicants for the CRI Irvington Postdoctoral Fellowship Program must be working in areas directly related to cancer immunology. An eligible project must fall into the broad field of immunology and must show relevance to solving the cancer problem. Proposals that do not encompass both these areas will not be considered.
Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment at the host institution.
Applicants with 5 or more years of relevant postdoctoral experience are not eligible, with the exception of M.D. applicants, who should not include years of residency in this calculation.
Only in exceptional circumstances will applicants who have already spent 3 or more years in a sponsor’s laboratory by the start date of fellowship be considered for a fellowship award.
The fellowship can be performed in the United States or abroad, but must take place at a non-profit institution.
There are no citizenship restrictions.
Only one fellow per sponsor may apply per application round, and faculty sponsors may not have more than three CRI-supported fellows at any time.
Financial Information
The fellowship provides a stipend of $50,000 for the first year, $53,000 for the second year, and $57,000 for the third year. In addition, an allowance of $1,500 per year is allotted to the host institution for use at the sponsor’s discretion to help pay for the fellow’s research supplies, travel to scientific meetings, and/or health insurance.
Deductions for administrative overhead are not allowed from either the stipend or the institutional allowance. Payments are made monthly in U.S. currency to the host institution.
Application Deadline
The application deadlines are April 1 and October 1; when those dates fall on the weekend, applications are due the following Monday. Applications are due by 5 p.m. EST on these dates. Applicants are notified of fellowship committee decisions within approximately 10-12 weeks of the application deadline.
Fellowships can be activated three months after the application deadline but no later than one year following the deadline. Awards activate on the first of the month.
Mail
Cancer Research Institute National Headquarters One Exchange Plaza 55 Broadway, Suite 1802 New York, NY 10006
Phone (800) 99-CANCER (800-992-2623) (212) 688-7515 Monday to Friday, 9 a.m. to 5 p.m. EST
Fax: (212) 832-9376
Damon Runyon-Rachleff Innovation Award
Application deadline: July 1, 2013
The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.
The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.
Awards are made to institutions for support of the Damon Runyon-Rachleff Innovation Investigators. All awards are approved by the Board of Directors of the Damon Runyon Cancer Research Foundation acting upon the recommendation of the Innovation Award Committee.
Applications will be evaluated based on the following:
The applicant’s capacity to conduct bold, exceptionally creative research.
The novelty and creativity of the proposed research. Incremental research will not be funded.
The potential of the proposed research to lead to advances that will significantly impact the prevention, diagnosis, treatment or basic understanding of cancer.
The applicant’s lack of resources to pursue the proposed research.
Program Sponsors
The Damon Runyon-Rachleff Innovation Award is funded by the generous support of Andrew and Debra Rachleff.
Institutional nominations are not required and there is no limit to the number of applications that can be received from a particular institution.
Applicants (including non-U.S. citizens) must be conducting independent research at a U.S. research institution.
Basic and translational/clinical projects will be considered. Applications will be accepted from all scientific disciplines provided that the proposed research meets the selection criteria.
Applicants with a background in multiple disciplines are especially encouraged to apply.
Joint submission from collaborators working in different disciplines will be considered. (The collaborators will share the $450,000 award.) Each collaborator must meet the eligibility criteria.
Applicants must belong to one of the following categories:
Tenure-track Assistant Professors within the first three years of obtaining their initial Assistant Professor position. (Cut-off date: July 1, 2010.)
Clinical Instructors and Senior Clinical Fellows (in the final year of their sub-specialty training) holding an MD who are pursuing a period of independent research before taking a tenure-track faculty position. Such individuals must have an exceptional record of research accomplishment, dedicated laboratory space and the support of their institution.
Distinguished Fellows with an exceptional record of research accomplishment identified by their institution to pursue an independent research program and who have dedicated laboratory space. These candidates are markedly distinct from traditional postdoctoral fellows. Examples: Whitehead Fellows, UCSF Fellows, Cold Spring Harbor Fellows.
[Research Assistant Professors, Research Associate Professors, Research Scientists and Postdoctoral Fellows are not eligible. If you are unsure about your eligibility for this award program, please contact the Foundation's Award Programs at 212.455.0520.]
Applicants are expected to commit a minimum of 80% of their time to conducting research.
Applicants may apply no more than two times.
Applicants must demonstrate that they have access to the resources and infrastructure necessary to conduct the proposed research.
The department must guarantee the Investigator is conducting the proposed research independently.
Funding
The award will be for a period of three years. Each award will provide a total of $450,000 in direct research costs. The Award cannot be used for indirect costs or institutional overhead.
Awards will be paid in increments of $150,000 per year for three years. However, the Innovation Award Committee will consider an accelerated payment schedule if an award recipient can demonstrate compelling need.
The Innovation Award funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator’s salary, salaries for professional and technical personnel, special equipment, supplies and other miscellaneous items required to conduct the proposed research.
The submitted budgets should be realistic estimates of the funds required for the proposed research and be itemized by category according to the instructions on the budget form.
No part of this award may be used for indirect costs or institutional overhead.
Concurrent Funding
Since the goal of the Innovation Award is to fund high risk/high reward research that lacks sufficient preliminary data to secure traditional funding, the applicant should not have funding for this proposed project.
During the course of the award, award recipients are encouraged to seek additional funding to expand and further develop their projects.
Contact Information:
Award Programs | 212.455.0520 | awards@damonrunyon.org
Damon Runyon-Sohn Pediatric Fellowship Award
Application due on or before: August 15, 2013
The Damon Runyon Cancer Research Foundation has joined together with the Sohn Conference Foundation, dedicated to curing pediatric cancers, to establish the Damon Runyon-Sohn Pediatric Cancer Fellowship Award. This award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers.
Candidates must apply for the fellowship under the guidance of a Sponsor—a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. In addition to aiding in the planning, execution and supervision of the proposed research, the Sponsor’s role is to foster the development of the Fellow’s overall knowledge, technical and analytical skills, and capacity for scientific inquiry. The Sponsor is also expected to assist the Fellow in attaining his/her career goals.
Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor. Candidates who have already accepted a postdoctoral research fellowship award are not eligible.
The primary criteria used to evaluate applicants are:
potential impact of the research on pediatric cancer
the quality of the research proposal (importance of the problem, originality of approach, appropriateness of techniques and clarity of presentation)
the qualifications, experience and productivity of both the candidate and the Sponsor
the quality of the research training environment in which the proposed research is to be conducted and its potential for broadening and strengthening the candidate’s ability to conduct innovative and substantive research. The proposed research and training environment should represent a new opportunity for the candidate to expand his/her scientific skill set. Direct extensions of the candidate’s graduate work (in approach, technique or exact area of study) will not be funded.
Damon Runyon-Sohn Pediatric Cancer Fellowships are granted for a three-year term with second- and third-year funding contingent upon satisfactory progress reports. Fellows in their first- and third-years of funding will attend Damon Runyon Fellows’ Retreats designed to foster collaboration and interaction between scientists working in different fields relevant to cancer.
All fellowship awards are approved by the Board of Directors of the Damon Runyon Cancer Research Foundation acting upon the recommendation of the Damon Runyon-Sohn Pediatric Cancer Fellowship Award Committee.
prev123next
